LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy
Crossref DOI link: https://doi.org/10.1007/s10238-015-0396-8
Published Online: 2015-10-16
Published Print: 2017-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Peng, Wei
Wu, Jianzhong
Feng, Jifeng
Text and Data Mining valid from 2015-10-16